Takeda Pharma GmbH, Germany - Case Study
Nov. 26, 2019
Courtesy ofBUCHI
“Takeda Pharma GmbH is controlling more than 30000 containers per year. NIR allows to save time without loosing safety.”
Customer name
Mr. Armin Groh, Laboratory Manager Quality Control
Company / Institution
Takeda Pharma GmbH, Germany
Product lines
Industries
Customer: Takeda Pharma GmbH, Germany
Takeda Pharma GmbH as part of the Japanese Takeda Group is a global pharmaceutical company, focussing on branded compounds as for gastroenterology, respiratory and infl ammation problems, pain, osteoporosis, and tissue management. A broad variety of OTC drugs completes the portfolio. The company has more than 10.000 employees all over the world and offers products in more than 100 countries. Takeda has a strong presence in Europe and in fast growing markets, such as Russia/CIS and Latin America. The company has its headquarter in Zurich, Switzerland and achieved a total turnover of ca. € 3,2 billion in 2010.
Application: Raw material identification within production
Customer avoids to control each container already in the warehouse. For Takeda there are major advantages to perform each single container identifi cation in the laboratory in parallel to the production (weighing process). Other international pharmceutical companies could also follow this example, because it`s very effi cient.
Equipment: NIRFlex® N-500
Raw materials are measured with the NIRFlex N-500. Solid and semi-solid samples are measured with measurement cell fi bre optic solids in diffuse refl ection. Liquid samples are measured in transmittance with measurement cell liquids.
Benefit / Conclusion: Unsupervised work, robust and durable
Speed up release, easier handling, each container just opened once for sampling, NIR measurements performed by higher qualifi ed stuff in the lab and avoiding logistic bottlenecks in the warehouse.
Takeda Pharma GmbH as part of the Japanese Takeda Group is a global pharmaceutical company, focussing on branded compounds as for gastroenterology, respiratory and infl ammation problems, pain, osteoporosis, and tissue management. A broad variety of OTC drugs completes the portfolio. The company has more than 10.000 employees all over the world and offers products in more than 100 countries. Takeda has a strong presence in Europe and in fast growing markets, such as Russia/CIS and Latin America. The company has its headquarter in Zurich, Switzerland and achieved a total turnover of ca. € 3,2 billion in 2010.
Application: Raw material identification within production
Customer avoids to control each container already in the warehouse. For Takeda there are major advantages to perform each single container identifi cation in the laboratory in parallel to the production (weighing process). Other international pharmceutical companies could also follow this example, because it`s very effi cient.
Equipment: NIRFlex® N-500
Raw materials are measured with the NIRFlex N-500. Solid and semi-solid samples are measured with measurement cell fi bre optic solids in diffuse refl ection. Liquid samples are measured in transmittance with measurement cell liquids.
Benefit / Conclusion: Unsupervised work, robust and durable
Speed up release, easier handling, each container just opened once for sampling, NIR measurements performed by higher qualifi ed stuff in the lab and avoiding logistic bottlenecks in the warehouse.
Most popular related searches
Stay in the loop!
Select your areas of interest to receive industry updates.